Although some diseases are rare, there is nonetheless a significant number of people suffering from them. There are between 6,000 and 8,000 rare diseases affecting a total of 6 to 8% of Belgian people.
What Sciensano does
Sciensano helps to implement some of the actions defined in the Belgian plan for rare diseases:
- Action 1: better financing for the diagnostic tests and monitoring of rare diseases, that are carried out in Belgium or abroad (feasibility study in progress)
- Action 2: quality management in the Centres for Human Genetics (feasibility study in progress)
- Action 16: the Central Registry of Rare Diseases centralises the data on patients affected by rare diseases in Belgium to improve care and to support research
- Action 17: Sciensano manages the Belgian part of the Orphanet site, an international network that collects all the information on rare diseases.
Central Registry of Rare Diseases
Sciensano is responsible for processing data from the Central Registry of Rare Diseases.
The Central Registry of Rare Diseases centralises data from all of the Belgian patients affected by rare diseases in order to:
- collect epidemiological data
- recruit patients more easily for research and clinical trials
- identify the measures needed in terms of healthcare.
The 8 centres for human genetics that are officially recognised in Belgium collect data for the Central Registry of Rare Diseases: Belgian medical centres for human genetics.
Orphanet is the international reference gateway for information on rare diseases and orphan drugs.
Orphanet aims to help improve diagnostics, care and treatment for patients affected by a rare disease.
Sciensano is responsible: